Bayer's Actron OTC ketoprofen set to launch "within weeks".

BAYER'S ACTRON OTC KETOPROFEN LAUNCH COMING "WITHIN WEEKS," the company said, following FDA's Oct. 6 approval of the 12.5 mg strength of the NSAID for OTC analgesic indications. Calling Actron "extremely important" to the company and promising a "formidable launch," Bayer said it intends to support its new Rx-to-OTC switch with major promotional campaigns directed at consumers, physicians and pharmacists.